DarioHealth Secures $17.5 Million Funding to Advance Digital Health Solutions

DarioHealth Secures Funding to Enhance Digital Health Solutions

DarioHealth Corp., a leading entity in the digital health arena, announces a critical private placement of 2,713,180 shares of common stock priced at $6.45 each, aiming to generate approximately $17.5 million in gross proceeds before expenses. The transaction is set to close around September 23, 2025, contingent upon the fulfillment of customary closing conditions. This capital infusion will primarily support general corporate purposes, underscoring DarioHealth's strategic focus on advancing its innovative digital health solutions. The offering adheres to exemptions from the registration requirements of the Securities Act of 1933, ensuring compliance with relevant state securities laws, and DarioHealth commits to filing a registration statement with the SEC to facilitate resale of the shares.

DarioHealth stands at the forefront of transforming chronic condition management through its comprehensive digital therapeutics platform. This user-centric solution integrates data analytics and personalized coaching to address various health issues, including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. By emphasizing continuous care and empowering users to make sustainable lifestyle changes, DarioHealth enhances user satisfaction and retention. The company's innovative approach not only provides immediate support for chronic conditions but also fosters long-term health improvements, thereby positioning DarioHealth as a pivotal player in the growing digital health landscape.

DarioHealth caters to a diverse clientele, including health plans, self-insured employers, and direct consumers, delivering high-quality digital health solutions across the globe. This funding initiative represents a crucial step in the company’s ongoing mission to revolutionize healthcare management for chronic conditions. By making proactive health interventions accessible and effective, DarioHealth is poised to lead the charge in improving health outcomes for individuals worldwide.

In addition to this funding announcement, DarioHealth continues to expand its reach and capabilities in the digital health sector. The company remains committed to leveraging technology to enhance user engagement and health outcomes. As it moves forward, DarioHealth's focus on innovation and user experience positions it well within the competitive landscape of digital health solutions. For further details about DarioHealth and its offerings, interested parties can visit their website at http://dariohealth.com.